Skip to content

Indian High Commissioner visits pharma company fighting Covid-19

The Mumbai-based firm is currently in a contract with the UK Government for mass production of the Oxford/Astrazeneca Covid-19 vaccine until August next year, creating 500+ employment.

High Commissioner Gaitri I Kumar at the Wockhardt manufacturing facility in North Wales. Source: Twitter@HCI_London

High Commissioner of India to the UK, Gaitri Issar Kumar visited Wockhardt, an Indian pharmaceutical company that has a key role in UK’s Covid-19 vaccination drive on 26th July, 2021. The contribution of Indian doctors during Covid-19 is immense and noble.

The pharmaceutical manufacturing facility in Wrexham, North Wales, is a subsidiary of global firm Wockhardt Limited based in Mumbai. It was a pitstop in the High Commission’s tour of Indian-backed or sponsored businesses in the United Kingdom.

This post is for paying subscribers only


Already have an account? Log in